<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00445263</url>
  </required_header>
  <id_info>
    <org_study_id>PC/AP 39-2005</org_study_id>
    <nct_id>NCT00445263</nct_id>
  </id_info>
  <brief_title>Comparison of Two Treatment Strategies in Patients With an Acute Coronary Syndrome Without ST Elevation</brief_title>
  <acronym>SISCA</acronym>
  <official_title>Treatment by Anti GP IIb/IIIa in the Setting of a Strategy of Early Coronarography to Patients With an Acute Coronary Syndrome Without ST Elevation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Avicenne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Avicenne</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The acute coronary syndrome (ACS) without ST elevation is a frequent pathology. The main
      evolutionary risk of these patients is the coronary thrombosis and its self complications.
      The platelets aggregation plays a major role in the physiopathology of the ACS. The
      therapeutic arsenal of the anti-thrombosis essentially resting on aspirin and heparin has
      been reinforced lately by the inhibitors of the glycoprotein anti GP IIb/IIIa. The profit of
      these products in the ACS with or without ST elevation, associated or not to coronarography,
      has clearly been demonstrated. This profit is more marked when patients are at high risk of
      complications. Thus, the use of an anti GP IIb/IIIa is recommended among patients at &quot;high
      risk&quot; for whom a coronarography is planned, in the last international recommendations of the
      European Cardiology Society (ESC), the American Heart Association and the American College of
      Chest Physician. Otherwise, some authors have proposed An early invasive strategy based on
      coronarography with discordant results. The ideal delay of realization of this coronarography
      is unknown. It varies according to the studies between 2.5 hours to 48 hours. Once again,
      patients at high risk seem to benefit the more of such a strategy if it is set precociously.

      Objective To compare an invasive strategy associating an early administration of tirofiban
      and a coronarography achieved in the 6 hours after the randomization to a conservative
      strategy in a population of high risk patients with ACS without ST elevation.

      Design Multicentric, prospective, randomized study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patient's selection Patient of more than 18 years with a ACS defined by a thoracic pain of
      more than 20 minutes that occurred during the last 24 hours, anomalies on EKG and one of the
      following criteria : diabetes; recurrence of coronary pain; precocious pain post-myocardial
      infarction; falling of the ST segment of &gt; 1 mm; transient elevation of the ST segment &gt; 1
      mm; elevation of the I troponin, T troponin or CPK MB; hemodynamic instability; ventricular
      arrhythmia; TIMI score &gt; 5

      Therapeutic modes All patients receive : aspirin, clopidogrel, enoxaparine. Trinitrin and
      analgesics are at the clinician's appreciation. Besides, either they receive an anti GP
      IIb/IIIa: tirofiban (Agrastat®) and are oriented in cardiology to have a coronarography in
      the six hours or they are oriented in cardiology to receive the classical treatment, guided
      by the investigations searching for signs of myocardial ischemia.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Because of inclusion delay
  </why_stopped>
  <start_date>March 2007</start_date>
  <completion_date type="Actual">July 2013</completion_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mortality, Myocardial Infarction and Revascularization in Emergency</measure>
    <time_frame>d30</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Therapeutic Failure (Well Defined) During the First 6 Hours. Clinical Evolution and Electrocardiography</measure>
    <time_frame>until the exit from the hospital and at d30.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Coronarographic Criteria : TIMI Score at the Beginning and the End of the Procedure; Existence of an Intra-coronary Thrombus</measure>
    <time_frame>d30</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Troponin Peak. Left Ventricular Ejection Fraction Before Hospital Exit. Length of Stay in USIC and Hospital. Hemorrhagic Complications.</measure>
    <time_frame>d30</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">170</enrollment>
  <condition>CORONARY DISEASE</condition>
  <arm_group>
    <arm_group_label>Early Invasive strategy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Tirofiban and coronarography within 6 hours</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Delayed invasive strategy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Coronarography after 6 hours</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>TIROFIBAN</intervention_name>
    <description>intravenous infusion</description>
    <arm_group_label>Early Invasive strategy</arm_group_label>
    <other_name>IIb/IIIa GP inhibitor</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>CORONAROGRAPHY</intervention_name>
    <description>standard procedure of coronarography</description>
    <arm_group_label>Early Invasive strategy</arm_group_label>
    <arm_group_label>Delayed invasive strategy</arm_group_label>
    <other_name>angiography</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  High risk ACS without ST elevation

        Exclusion Criteria:

          -  Age &lt;18 years

          -  Pregnancy

          -  Persistence of the ST elevation

          -  Recent left branch block

          -  Cardiac failure or cardiogenic shock (Kilip 3 or 4)

          -  Treatment by anti-vitamin K

          -  Contra-indication to the use of one of the following treatments: aspirin, clopidogrel,
             enoxaparine, anti GP IIb/IIIa (tirofiban)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>FREDERIC LAPOSTOLLE, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>SAMU 93 - AVICENNE HOSPITAL</affiliation>
  </overall_official>
  <overall_official>
    <last_name>FREDERIC ADNET, PHD</last_name>
    <role>Study Director</role>
    <affiliation>SAMU 93 - AVICENNE HOSPITAL</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Samu 93 - Chu Avicenne</name>
      <address>
        <city>Bobigny</city>
        <state>Ile de France</state>
        <zip>93000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 7, 2007</study_first_submitted>
  <study_first_submitted_qc>March 7, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 8, 2007</study_first_posted>
  <results_first_submitted>January 26, 2015</results_first_submitted>
  <results_first_submitted_qc>January 26, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">February 9, 2015</results_first_posted>
  <last_update_submitted>February 9, 2015</last_update_submitted>
  <last_update_submitted_qc>February 9, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 27, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Avicenne</investigator_affiliation>
    <investigator_full_name>FREDERIC LAPOSTOLLE</investigator_full_name>
    <investigator_title>Frédéric Lapostolle</investigator_title>
  </responsible_party>
  <keyword>CORONARY DISEASE</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Coronary Syndrome</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tirofiban</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Early Invasive Strategy</title>
          <description>Tirofiban and coronarography within six hours</description>
        </group>
        <group group_id="P2">
          <title>Delayed Invasive Strategy</title>
          <description>Coronarography after six hours</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="83"/>
                <participants group_id="P2" count="87"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="83"/>
                <participants group_id="P2" count="86"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Early Invasive Strategy</title>
          <description>Tirofiban and coronarography within six hours</description>
        </group>
        <group group_id="B2">
          <title>Delayed Invasive Strategy</title>
          <description>Coronarography after six hours</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="83"/>
            <count group_id="B2" value="86"/>
            <count group_id="B3" value="169"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="63.9" lower_limit="55.6" upper_limit="72.5"/>
                    <measurement group_id="B2" value="66.5" lower_limit="57.5" upper_limit="75.8"/>
                    <measurement group_id="B3" value="65.3" lower_limit="57.1" upper_limit="75.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="58"/>
                    <measurement group_id="B2" value="63"/>
                    <measurement group_id="B3" value="121"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>BMI</title>
          <units>kg/m2</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27.0" lower_limit="23.6" upper_limit="29.4"/>
                    <measurement group_id="B2" value="26.6" lower_limit="24.2" upper_limit="30.4"/>
                    <measurement group_id="B3" value="26.6" lower_limit="24.1" upper_limit="30.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Family history of CVS disease</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="63"/>
                    <measurement group_id="B2" value="64"/>
                    <measurement group_id="B3" value="127"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Current smoker</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="44"/>
                    <measurement group_id="B2" value="41"/>
                    <measurement group_id="B3" value="85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="39"/>
                    <measurement group_id="B2" value="45"/>
                    <measurement group_id="B3" value="84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Diabetes mellitus</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="35"/>
                    <measurement group_id="B2" value="28"/>
                    <measurement group_id="B3" value="63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="48"/>
                    <measurement group_id="B2" value="58"/>
                    <measurement group_id="B3" value="106"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Hypertension</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="50"/>
                    <measurement group_id="B2" value="51"/>
                    <measurement group_id="B3" value="101"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33"/>
                    <measurement group_id="B2" value="35"/>
                    <measurement group_id="B3" value="68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Dyslipidemia</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="45"/>
                    <measurement group_id="B2" value="45"/>
                    <measurement group_id="B3" value="90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="38"/>
                    <measurement group_id="B2" value="41"/>
                    <measurement group_id="B3" value="79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Previous MI</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64"/>
                    <measurement group_id="B2" value="66"/>
                    <measurement group_id="B3" value="130"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Previous PCI</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="63"/>
                    <measurement group_id="B2" value="68"/>
                    <measurement group_id="B3" value="131"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Previous CABG</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="75"/>
                    <measurement group_id="B2" value="82"/>
                    <measurement group_id="B3" value="157"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>On aspirin</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="39"/>
                    <measurement group_id="B2" value="32"/>
                    <measurement group_id="B3" value="71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="44"/>
                    <measurement group_id="B2" value="54"/>
                    <measurement group_id="B3" value="98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Mortality, Myocardial Infarction and Revascularization in Emergency</title>
        <time_frame>d30</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Early Invasive Strategy</title>
            <description>Tirofiban and coronarography within six hours</description>
          </group>
          <group group_id="O2">
            <title>Delayed Invasive Strategy</title>
            <description>Coronarography after six hours</description>
          </group>
        </group_list>
        <measure>
          <title>Mortality, Myocardial Infarction and Revascularization in Emergency</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="83"/>
                <count group_id="O2" value="86"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Therapeutic Failure (Well Defined) During the First 6 Hours. Clinical Evolution and Electrocardiography</title>
        <time_frame>until the exit from the hospital and at d30.</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Coronarographic Criteria : TIMI Score at the Beginning and the End of the Procedure; Existence of an Intra-coronary Thrombus</title>
        <time_frame>d30</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Troponin Peak. Left Ventricular Ejection Fraction Before Hospital Exit. Length of Stay in USIC and Hospital. Hemorrhagic Complications.</title>
        <time_frame>d30</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>30 days</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Early Invasive Strategy</title>
          <description>Tirofiban and coronarography within six hours</description>
        </group>
        <group group_id="E2">
          <title>Delayed Invasive Strategy</title>
          <description>Coronarography after six hours</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="83"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="86"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Major bleeding</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="83"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="86"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="86"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Pr Frédéric Lapostolle</name_or_title>
      <organization>SAMU 93</organization>
      <phone>0033148964454</phone>
      <email>frederic.lapostolle@avc.aphp.fr</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

